- Retrospective cohort of adult cardiac surgery patients using cell salvage, analyzed as a routine coagulation cohort (N = 677) and an exploratory viscoelastic cohort (N = 50).
- Exposure was cell salvage reinfusion volume, with paired hemostatic measurements before and after and no coagulation-affecting blood products between them.
- In the routine coagulation cohort, CS volume was not significantly associated with absolute changes in any parameter (all p ≥ 0.144).
- In the viscoelastic cohort, higher CS volume was associated with lower functional fibrinogen clot strength (CFF MA β = -3.31 mm/L; 95% CI -5.53 to -1.08; adjusted p = 0.031), while the CK MA association did not survive correction.
Latest papers
Results for “transfusion cardiac restrictive OR transfusion cardiac liberal”.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This single-center, retrospective before-after study compared 229 elective cardiac surgery patients on an ERAS-PBM pathway with 162 pre-ERAS patients from 2019.
- The ERAS-PBM pathway added preoperative anemia screening and treatment, adherence to restrictive transfusion thresholds, blood conservation, and care bundles run by an ERAS nurse.
- RBC transfusion fell from 38.9% to 23.6% (p = 0.0012), and the exploratory adjusted OR for transfusion was 0.59 (95% CI 0.36-0.98; p = 0.041).
- Complications fell from 66.7% to 46.3% and hospital stay shortened from 12 to 9 days, and the authors call for larger multicenter prospective studies.
- This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
- It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
- Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
- Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
- Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
- Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
- No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
- The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.